Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762443
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia AreataJiangsu vcare pharmaceutical technology co., LTDNot Yet RecruitingPhase 1
NCT07762443Not Yet Recruiting
Phase 1
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Are...Jiangsu vcare pharmaceuti...
NCT07761962
Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversible PulpitisKing Abdullah University HospitalActive Not RecruitingNot Applicable
NCT07761962Active Not Recruiting
Not Applicable
Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversib...King Abdullah University...
NCT07763626
Gdue Plus a Hypocaloric Mediterranean Diet in Adults With MASLDUniversity of GenovaCompletedNot Applicable
NCT07763626Completed
Not Applicable
Gdue Plus a Hypocaloric Mediterranean Diet in Adults With MASLDUniversity of Genova
NCT07762716
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762716Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTr...BreakBio Corp
NCT07763379
THE ROLE OF C-REACTIVE PROTEIN (CRP) IN THE EARLY DIAGNOSIS OF ANASTOMOTIC LEAKAGE FOLLOWING PRIMARY REPAIR IN GASTROINTESTINAL SURGERYSohag UniversityRecruiting
NCT07763379Recruiting
—
THE ROLE OF C-REACTIVE PROTEIN (CRP) IN THE EARLY DIAGNOSIS OF ANASTOMOTIC LEAKA...Sohag University
NCT07762872
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSDChifeng Municipal HospitalRecruiting
NCT07762872Recruiting
—
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in...Chifeng Municipal Hospita...
NCT07763756
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer SurgeryAntalya City HospitalNot Yet RecruitingNot Applicable
NCT07763756Not Yet Recruiting
Not Applicable
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer Surg...Antalya City Hospital
NCT07762001
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MDActive Not RecruitingPhase 1
NCT07762001Active Not Recruiting
Phase 1
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MD
NCT07762157
The Effectiveness of Tele-pulmonary Rehabilitation Program on People With Chronic Obstructive Pulmonary Disease (COPD) After Hospitalization for Acute ExacerbationNorth District HospitalRecruitingNot Applicable
NCT07762157Recruiting
Not Applicable
The Effectiveness of Tele-pulmonary Rehabilitation Program on People With Chroni...North District Hospital
NCT07762924
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving SurgeryFudan UniversityRecruitingPhase 2
NCT07762924Recruiting
Phase 2
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Fol...Fudan University
NCT07763314
Trends and Short-term Outcomes of Surgically Resected Early-onset Colorectal Cancer in Switzerland Between 2003 and 2022Cantonal Hospital of St. GallenCompleted
NCT07763314Completed
—
Trends and Short-term Outcomes of Surgically Resected Early-onset Colorectal Can...Cantonal Hospital of St....
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07763106
Effectiveness and Costs of Pressure Ulcer Treatment and the Quality of Life of Patients With Pressure Ulcers Receiving Home-Based and Institutional CareSalus Care Center, Rybnik, PolandNot Yet RecruitingNot Applicable
NCT07763106Not Yet Recruiting
Not Applicable
Effectiveness and Costs of Pressure Ulcer Treatment and the Quality of Life of P...Salus Care Center, Rybnik...
NCT07762300
Hybrid Transobturator Tape Versus Conventional Synthetic Tape for Stress Urinary IncontinenceBenha UniversityRecruitingNot Applicable
NCT07762300Recruiting
Not Applicable
Hybrid Transobturator Tape Versus Conventional Synthetic Tape for Stress Urinary...Benha University
NCT07762027
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus InfectionAssembly BiosciencesNot Yet RecruitingPhase 2
NCT07762027Not Yet Recruiting
Phase 2
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Part...Assembly Biosciences
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUPNot Yet RecruitingPhase 2
NCT07763496Not Yet Recruiting
Phase 2
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUP
NCT07764081
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764081Recruiting
—
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, N...
NCT07763132
Comparison of Virtual Reality, EMLA Cream, and Standard Care for Pain During Blood Draws in ChildrenMarie LulkováRecruitingNot Applicable
NCT07763132Recruiting
Not Applicable
Comparison of Virtual Reality, EMLA Cream, and Standard Care for Pain During Blo...Marie Lulková
NCT07762703
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762703Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metasta...BreakBio Corp
Result Breakdown
Not yet recruiting9 (45%)
Recruiting7 (35%)
Active, not recruiting2 (10%)
Completed2 (10%)
not_applicable7 (35%)
Phase 14 (20%)
Not Specified4 (20%)
Phase 24 (20%)
Phase 41 (5%)